D-Index & Metrics Best Publications
Microbiology
Spain
2022

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 86 Citations 23,046 253 World Ranking 212 National Ranking 4

Research.com Recognitions

Awards & Achievements

2022 - Research.com Microbiology in Spain Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Microbiology
  • Fungus

Manuel Cuenca-Estrella spends much of his time researching Microbiology, Amphotericin B, Internal medicine, Voriconazole and Fluconazole. Microbiology and Fungal protein are commonly linked in his work. His Amphotericin B research integrates issues from Ribosomal RNA, Broth microdilution and Etest.

His research in Internal medicine intersects with topics in Surgery, Fungemia and Aspergillosis. The various areas that Manuel Cuenca-Estrella examines in his Fluconazole study include Candida parapsilosis, Candida glabrata and Candida tropicalis. Manuel Cuenca-Estrella works mostly in the field of Aspergillus fumigatus, limiting it down to topics relating to Aspergillus and, in certain cases, Mucorales and Fusarium, as a part of the same area of interest.

His most cited work include:

  • ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. (751 citations)
  • ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013 (543 citations)
  • Epidemiology and Predictors of Mortality in Cases of Candida Bloodstream Infection: Results from Population-Based Surveillance, Barcelona, Spain, from 2002 to 2003 (519 citations)

What are the main themes of his work throughout his whole career to date?

Manuel Cuenca-Estrella mostly deals with Microbiology, Amphotericin B, Aspergillus, Antifungal and Fluconazole. His study in Microbiology focuses on Voriconazole, Itraconazole, Aspergillus fumigatus, Azole and Candida albicans. His Amphotericin B study combines topics from a wide range of disciplines, such as In vitro, Broth microdilution, Fungi imperfecti and Cryptococcus neoformans.

Manuel Cuenca-Estrella has researched Aspergillus in several fields, including Mucorales, Aspergillosis and Fusarium. His Fluconazole research is multidisciplinary, incorporating perspectives in Internal medicine, Minimum inhibitory concentration and Mycosis. Manuel Cuenca-Estrella works mostly in the field of Internal medicine, limiting it down to concerns involving Surgery and, occasionally, Incidence.

He most often published in these fields:

  • Microbiology (54.55%)
  • Amphotericin B (20.61%)
  • Aspergillus (18.18%)

What were the highlights of his more recent work (between 2014-2021)?

  • Microbiology (54.55%)
  • Internal medicine (15.15%)
  • Aspergillus (18.18%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Microbiology, Internal medicine, Aspergillus, Aspergillosis and Intensive care medicine. His study involves Amphotericin B, Itraconazole, Broth microdilution, Scedosporium and Drug resistance, a branch of Microbiology. His Amphotericin B research is multidisciplinary, incorporating elements of Aspergillus calidoustus, Voriconazole, Candida glabrata and Pathology.

His Internal medicine study combines topics in areas such as Gastroenterology, Fluconazole and Surgery. The Aspergillus study combines topics in areas such as Aspergillus fumigatus, Fusarium, Mucorales, Antifungal and Polymerase chain reaction. His Aspergillosis study incorporates themes from Gene and Transplantation.

Between 2014 and 2021, his most popular works were:

  • Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline (417 citations)
  • Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (285 citations)
  • Serum Galactomannan Versus a Combination of Galactomannan and Polymerase Chain Reaction–Based Aspergillus DNA Detection for Early Therapy of Invasive Aspergillosis in High-Risk Hematological Patients: A Randomized Controlled Trial (101 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Fungus

His primary scientific interests are in Internal medicine, Aspergillus, Aspergillosis, Intensive care medicine and Microbiology. His studies in Internal medicine integrate themes in fields like Gastroenterology, Fluconazole, Surgery and Candida tropicalis. His biological study spans a wide range of topics, including Aspergillus fumigatus and Polymerase chain reaction.

His Aspergillosis research incorporates elements of Echinocandin, Caspofungin, Posaconazole, Micafungin and Transplantation. In his papers, he integrates diverse fields, such as Microbiology and Antimicrobial susceptibility. Manuel Cuenca-Estrella works mostly in the field of Drug resistance, limiting it down to topics relating to Amphotericin B and, in certain cases, Voriconazole.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

O.A. Cornely;M. Bassetti;T. Calandra;J. Garbino.
Clinical Microbiology and Infection (2012)

1024 Citations

Epidemiology and Predictors of Mortality in Cases of Candida Bloodstream Infection: Results from Population-Based Surveillance, Barcelona, Spain, from 2002 to 2003

Benito Almirante;Dolors Rodríguez;Benjamin J Park;Manuel Cuenca-Estrella.
Journal of Clinical Microbiology (2005)

809 Citations

EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts.

J.L. Rodriguez-Tudela;M.C. Arendrup;F. Barchiesi;J. Bille.
Clinical Microbiology and Infection (2008)

751 Citations

A New Aspergillus fumigatus Resistance Mechanism Conferring In Vitro Cross-Resistance to Azole Antifungals Involves a Combination of cyp51A Alterations

E. Mellado;G. Garcia-Effron;L. Alcázar-Fuoli;W. J. G. Melchers.
Antimicrobial Agents and Chemotherapy (2007)

564 Citations

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

A. J. Ullmann;J. M. Aguado;S. Arikan-Akdagli;D. W. Denning.
Clinical Microbiology and Infection (2018)

563 Citations

ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013

O.A. Cornely;S. Arikan-Akdagli;E. Dannaoui;A.H. Groll.
Clinical Microbiology and Infection (2014)

543 Citations

Saccharomyces cerevisiae Fungemia: An Emerging Infectious Disease

Patricia Muñoz;Emilio Bouza;Manuel Cuenca-Estrella;Jose María Eiros.
Clinical Infectious Diseases (2005)

480 Citations

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

J. Peter Donnelly;Sharon C. Chen;Carol A. Kauffman;William J. Steinbach.
Clinical Infectious Diseases (2020)

431 Citations

EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)*

Maiken C. Arendrup;Manuel Cuenca-Estrella;Cornelia Lass-Flörl;William Hope.
Clinical Microbiology and Infection (2012)

404 Citations

Head-to-Head Comparison of the Activities of Currently Available Antifungal Agents against 3,378 Spanish Clinical Isolates of Yeasts and Filamentous Fungi

Manuel Cuenca-Estrella;Alicia Gomez-Lopez;Emilia Mellado;Maria J. Buitrago.
Antimicrobial Agents and Chemotherapy (2006)

397 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Manuel Cuenca-Estrella

Jacques F. Meis

Jacques F. Meis

Canisius-Wilhelmina Ziekenhuis

Publications: 170

Paul E. Verweij

Paul E. Verweij

Radboud University Nijmegen

Publications: 158

Maiken Cavling Arendrup

Maiken Cavling Arendrup

Statens Serum Institut

Publications: 152

Oliver A. Cornely

Oliver A. Cornely

University of Cologne

Publications: 143

Sharon C.-A. Chen

Sharon C.-A. Chen

University of Sydney

Publications: 127

Thomas J. Walsh

Thomas J. Walsh

Weill Cornell Medicine

Publications: 117

Patricia Muñoz

Patricia Muñoz

Hospital General Universitario Gregorio Marañón

Publications: 116

Josep Guarro

Josep Guarro

Rovira i Virgili University

Publications: 112

Eric Dannaoui

Eric Dannaoui

Université Paris Cité

Publications: 110

Jesús Guinea

Jesús Guinea

Hospital General Universitario Gregorio Marañón

Publications: 106

Emilio Bouza

Emilio Bouza

Hospital General Universitario Gregorio Marañón

Publications: 105

Olivier Lortholary

Olivier Lortholary

Université Paris Cité

Publications: 102

David W. Denning

David W. Denning

University of Manchester

Publications: 101

Teun Boekhout

Teun Boekhout

University of Amsterdam

Publications: 101

Arnaldo Lopes Colombo

Arnaldo Lopes Colombo

Federal University of Sao Paulo

Publications: 98

Michael A. Pfaller

Michael A. Pfaller

JMI Laboratories

Publications: 94

Something went wrong. Please try again later.